Half of Ebola outbreaks have gone undetected since the virus was discovered in...
Half of Ebola outbreaks have gone undetected since the virus was discovered in 1976, scientists at the University of Cambridge estimate.

Source: University of Cambridge

News • Study

Half of Ebola outbreaks go undetected

Half of Ebola outbreaks have gone undetected since the virus was discovered in 1976, scientists at the University of Cambridge estimate. The new findings come amid rising concern about Ebola in the Democratic Republic of Congo, and highlight the need for improved detection and rapid response to avoid future epidemics.

The research, led by Emma Glennon from Cambridge's Department of Veterinary Medicine, is the first to estimate the number of undetected Ebola outbreaks. Although these tend to involve clusters of fewer than five people, they could represent well over 100 patient cases in total. The study, published today in PLOS Neglected Tropical Diseases, found that the chance of detecting an isolated case of Ebola was less than 10 per cent.

Glennon, a Gates Cambridge Scholar, says: "Most times that Ebola has jumped from wildlife to people, this spillover event hasn't been detected. Often these initial cases don't infect anyone else but being able to find and control them locally is crucial because you never know which of these events will grow into full outbreaks."

"We rarely find Ebola outbreaks while they are still easy to manage. The unfolding epidemic in the DRC demonstrates how difficult it is to stop the disease once it has got out of control, even with international intervention. But if an outbreak is detected early enough, we can prevent it spreading with targeted, low-tech interventions, such as isolating infected people and their contacts."

The scientists used three independent datasets from the 2013-16 Ebola epidemic in West Africa to simulate thousands of outbreaks. From these simulations, they worked out how often they would expect a spillover event to fizzle out early versus how often they would expect to see it progress into a true outbreak. This allowed the team to draw comparisons with reported outbreak sizes and estimate detection rates of clusters of different sizes.

Glennon says: "Most doctors and public health workers have never seen a single Ebola case and severe fever can easily be misdiagnosed as the symptom of malaria, typhoid or yellow fever. To limit outbreaks at their source, we need to invest much more to increase local capacity to diagnose and contain Ebola and these more common fevers. We must make sure every local clinic has basic public health and infection control resources. International outbreak responses are important but they are often slow, complicated and expensive."

Source: University of Cambridge

18.06.2019

Read all latest stories

Related articles

Photo

News • Viral aftereffects

Long Covid: Six in ten have at least one symptom one year after infection

Six in ten people with Covid-19 still have at least one symptom a year later, a new study has found. Furthermore, symptoms that don’t clear up after 15 weeks are likely to last at least a year.

Photo

News • Global study finds increase in deaths

Why is Covid-19 more deadly on weekends?

A global analysis of nearly 6 million Covid-19 deaths finds an increase in mortality at weekends compared to weekdays. Bureaucratic and reporting delays alone do not explain this, researchers report.

Photo

News • Effective prevention

Covid-19 vaccination greatly reduces infectious viral load

By comparing the infectious viral load caused by ancestral SARS-CoV-2 as well as by the Delta and Omicron variants, scientists highlight the benefits of vaccination.

Related products

Associates of Cape Cod – Fungitell STAT Assay

Identification/Susceptibility

Associates of Cape Cod – Fungitell STAT Assay

Associates of Cape Cod Europe GmbH
Hologic – Novodiag System

Automation & sample processing

Hologic – Novodiag System

Hologic, Inc.
Siemens Healthineers – teamplay Images

Portal Solutions

Siemens Healthineers – teamplay Images

Siemens Healthineers
Siemens Healthineers – Versant HCV Genotype 2.0 Assay (LiPA)

Infectious Disease/Hepatitis

Siemens Healthineers – Versant HCV Genotype 2.0 Assay (LiPA)

Siemens Healthineers
Subscribe to Newsletter